CHICAGO, Dec. 4 /PRNewswire-FirstCall/ -- The Female Health Company
(OTC:FHCO) (BULLETIN BOARD: FHCO) today reported financial results
for the fourth quarter and full-year of fiscal 2006. HIGHLIGHTS: --
4th Qtr. Revenue: $4.4 million up 47% over 4th Qtr. of FY2005 --
FY2006 revenue: $14.8 million up 33% year over year -- 4th Qtr. net
income: $52,105 up $189,001 from 4th Qtr. FY2005 loss of ($136,896)
-- FY2006 net income: $120,778 up $1,637,641 from FY2005 loss of
($1,516,863) -- Cash: $2,065,134 up $290,068 or 16% from FY2005
Quarterly Results: For the fourth fiscal quarter ended September
30, 2006, the Company reported revenue of $4,422,103, as compared
with $3,001,321 for the comparable period last year, an increase of
$1,420,782 or 47%. The revenue growth resulted from increased
demand from the global public sector. Net income attributable to
common shareholders was $52,105 or $.00 per diluted share versus a
net loss of $(136,896), or $(.01) per diluted share for the three
months ended September 30, 2005. Full Year Results: For the year
ended September 30, 2006, the Company reported total revenues of
$14,824,242 compared with revenues of $11,161,555 for the prior
year, an increase of $3,662,687 or 33%. During fiscal year 2006,
the Company sold 19.6 million units, up 41% from fiscal year 2005.
Net income attributable to common shareholders for the year ended
September 30, 2006 was $120,778 ($.01 per diluted share), an
$1,637,641 improvement over the fiscal year 2005 loss of
$(1,516,863), or ($(.07) per diluted share). The Company expects
significant quarter to quarter variations due to the timing of
large orders and shipment. About the Female Health Company. The
Female Health Company, based in Chicago, Illinois, manufactures and
markets the FC Female Condom(R), which is primarily distributed by
public health organizations and donor groups in over 90 developing
countries around the world. World-wide, the Female Condom is
available in various programs in 108 countries. The Company owns
certain worldwide rights to the FC Female Condom(R), including
patents that have been issued in the United States, United Kingdom,
Japan, France, Italy, Germany, Spain, the European Patent
Convention, the People's Republic of China, Canada, South Korea and
Australia. FC Female Condom(R) is the only available FDA-approved
product controlled by a woman that offers dual protection against
sexually transmitted diseases, including HIV/AIDS, and unintended
pregnancy. "Safe Harbor" statement under the Private Securities
Litigation Reform Action of 1995: The statements in this release
which are not historical fact are forward-looking statements based
upon the Company's current plan and strategies, and reflect the
Company's current assessment of the risks and uncertainties related
to its business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and
supply constraints; and other risks detailed in the Company's press
releases, shareholder communication and Securities and Exchange
Commission filings. Actual events affecting the Company and the
impact of such events on the Company's operations may vary from
those currently anticipated. For more information about the Female
Health Company visit the Company's website at
http://www.femalehealth.com/ and http://www.femalecondom.org/ . If
you would like to be added to the Company's e-mail alert list,
please send an e-mail to . THE FEMALE HEALTH COMPANY Unaudited
Condensed Consolidated Balance Sheet September 30, September 30,
2006 2005 Cash $1,827,393 $1,775,066 Restricted cash 237,741 -
Accounts receivable, net 3,160,801 2,040,476 Inventory 1,011,672
883,709 Prepaid and other current assets 582,457 344,383 Total
current assets 6,820,064 5,043,634 Other non-current assets 187,940
277,368 Net property, plant & equipment 437,766 358,149 TOTAL
ASSETS $7,445,770 $5,679,151 Accounts payable $599,022 $559,414
Accrued expenses 970,439 664,709 Preferred dividends payable 11,210
11,201 Total current liabilities 1,580,671 1,235,324 Deferred gain
on sale of facility 1,092,775 1,134,003 Total liabilities 2,673,446
2,369,327 Total stockholders' equity 4,772,324 3,309,824 TOTAL
LIABILITIES AND EQUITY $7,445,770 $5,679,151 THE FEMALE HEALTH
COMPANY Unaudited Condensed Consolidated Income Statements For the
3 Months Ended For the 12 Months Ended September 30, September 30,
2006 2005 2006 2005 NET REVENUES $4,422,103 $3,001,321 $14,824,242
$11,161,555 GROSS PROFIT 1,513,908 1,235,411 5,489,409 4,043,833
Advertising and promotion 60,237 77,418 218,500 123,103 Selling,
general & administrative 1,276,759 1,185,800 4,819,678
4,958,208 Research and development 95,360 72,598 210,876 273,776
Total Operating Expenses 1,432,356 1,335,816 5,249,054 5,355,087
OPERATING INCOME(LOSS) 81,552 (100,405) 240,355 (1,311,254)
Interest, net and other expense (11,196) (4,153) (41,671) 44,402
Pretax income (loss) 92,748 (96,252) 282,026 (1,355,656) Income
taxes - - - - NET INCOME(LOSS) 92,748 (96,252) 282,026 (1,355,656)
Preferred dividends 40,643 40,644 161,248 161,207 NET INCOME(LOSS)
ATTRIBUTABLE TO COMMON STOCKHOLDERS $52,105 $(136,896) $120,778
$(1,516,863) BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE
$0.00 $(0.01) $0.01 $(0.07) Weighted avg. common shares - Basic and
Diluted 24,285,630 23,468,080 23,948,729 23,094,868 DATASOURCE: The
Female Health Company CONTACT: William R. Gargiulo, Jr.,
+1-231-526-1244, or Donna Felch, +1-312-595-9742, both of The
Female Health Company Web site: http://www.femalehealth.com/
http://www.femalecondom.org/
Copyright
